ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ - ScienceDirect
Transplantology | Free Full-Text | Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review
Systemic immunity in cancer | Nature Reviews Cancer
Pathogens | Free Full-Text | Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases
Immunocompromised Populations
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology
Table 1 from Immunosuppressive therapy in lung transplantation: state of the art. | Semantic Scholar
Frontiers | Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis | PNAS
The burden of cutaneous disease in solid organ transplant recipients of color - American Journal of Transplantation
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias | JACC: Clinical Electrophysiology
Cancer Risk Among Immunosuppressed Populations - NCI
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms | Oncogenesis
Targeted Therapy and Immunosuppression in the Tumor Microenvironment: Trends in Cancer
H.R. 5534 Passed: Lifetime Medicare Coverage of Immunosuppressant for Kidney Recipients - American Transplant Foundation
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
Frontiers | Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial - American Journal of Transplantation
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy - ScienceDirect
Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
